Of note, imatinib treatment of the Ph‐positive ALL cell line downregulated CD49f expression and disrupted laminin adhesion, indicating that BCR::ABL1 itself is involved in high levels of CD49f expression and subsequently the laminin‐binding properties in Ph‐positive ALL. Here, BCR is linked to acute lymphoblastic leukemia.